Replies to post #64 on Biovest International Inc.(fka BVTIQ)

[investor911]

"BVTI plan to make BiovaxID available throughout most of Europe on a named-patient basis. This compassionate-use drug access program allows European physicians to prescribe drugs to qualifying patients before approvals are granted, assuming the protocols for each participating country are followed."

Float is real thin here.